What Works in the Treatment of Borderline Personality Disorder

Current Behavioral Neuroscience Reports

Volumn 4, Issue 1, 2017, Pages 21-30

  Choi Kain, Lois W ^a   Finch, Ellen F ^a   Masland, Sara R ^a   Jenkins, James A ^b   Unruh, Brandon T ^a  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Borderline personality disorder; Dialectical behavior therapy; General psychiatric management; Mentalization based treatment; Psychotherapy; Schema focused therapy; Transference focused psychotherapy

Indexed keywords

EID: 85037660550     PISSN: None     EISSN: 21962979     Source Type: Journal    
DOI: 10.1007/s40473-017-0103-z     Document Type: Review

References (64)

1. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. American journal of Psychiatry. 1999.
2. Giesen-Bloo J, Van Dyck R, Spinhoven P, Van Tilburg W, Dirksen C, Van Asselt T, et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry. 2006;63(6):649–58. DOI: 10.1001/archpsyc.63.6.649
3. Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF. Evaluating three treatments for borderline personality disorder: a multiwave study. American Journal of Psychiatry. 2007.
4. Blum N, St. John D, Pfohl B, Stuart S, McCormick B, Allen J, et al. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatr. 2008;165(4):468–78. DOI: 10.1176/appi.ajp.2007.07071079
5. Stoffers JM, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. The Cochrane Library. 2012.
6. Ingenhoven T. Pharmacotherapy for borderline patients: business as usual or by default? The Journal of clinical psychiatry. 2015;76(4):522–3. DOI: 10.4088/JCP.14com09522
7. Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010;196(1):4–12. DOI: 10.1192/bjp.bp.108.062984
8. • Gunderson JG, Links PS. Handbook of good psychiatric management for borderline personality disorder. American Psychiatric Pub; 2014. This is a practical handbook of how to employ a generalist model of BPD care.
9. Koons CR, Robins CJ, Tweed JL, Lynch TR, Gonzalez AM, Morse JQ, et al. Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behav Ther. 2001;32(2):371–90. DOI: 10.1016/S0005-7894(01)80009-5
10. Linehan MM, Tutek DA, Heard HL, Armstrong HE. Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. Am J Psychiatry. 1994;151(12):1771–6. doi:10.1176/ajp.151.12.1771. DOI: 10.1176/ajp.151.12.1771
11. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1991;48(12):1060–4. DOI: 10.1001/archpsyc.1991.01810360024003
12. Carter GL, Willcox CH, Lewin TJ, Conrad AM, Bendit N. Hunter DBT project: randomized controlled trial of dialectical behaviour therapy in women with borderline personality disorder. Aust N Z J Psychiatry. 2010;44(2):162–73. DOI: 10.3109/00048670903393621
13. Priebe S, Bhatti N, Barnicot K, Bremner S, Gaglia A, Katsakou C, et al. Effectiveness and cost-effectiveness of dialectical behaviour therapy for self-harming patients with personality disorder: a pragmatic randomised controlled trial. Psychother Psychosom. 2012;81(6):356–65. DOI: 10.1159/000338897
14. Steil R, Krüger A, Dyer A, Priebe K, Feldmann Jr RE, Bohus M. DBT-PTSD. Trauma und Gewalt. 2010;4(2):106–17.
15. • Bohus M, Dyer AS, Priebe K, Krüger A, Kleindienst N, Schmahl C, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013;82(4):221–33. This paper provides evidence of a changing practice in managing comorbid PTSD and BPD. DOI: 10.1159/000348451
16. Rossouw TI, Fonagy P. Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry. 2012;51(12):1304–13. e3 DOI: 10.1016/j.jaac.2012.09.018
17. Davidson K, Norrie J, Tyrer P, Gumley A, Tata P, Murray H, et al. The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Personal Disord. 2006;20(5):450. DOI: 10.1521/pedi.2006.20.5.450
18. Weinberg I, Gunderson JG, Hennen J, Cutter Jr CJ. Manual assisted cognitive treatment for deliberate self-harm in borderline personality disorder patients. J Personal Disord. 2006;20(5):482–92. DOI: 10.1521/pedi.2006.20.5.482
19. Bos EH, van Wel EB, Appelo MT, Verbraak MJ. A randomized controlled trial of a Dutch version of systems training for emotional predictability and problem solving for borderline personality disorder. J Nerv Ment Dis. 2010;198(4):299–304. DOI: 10.1097/NMD.0b013e3181d619cf
20. Gregory RJ, Chlebowski S, Kang D, Remen AL, Soderberg MG, Stepkovitch J, et al. A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder. Psychother Theory Res Pract Train. 2008;45(1):28. DOI: 10.1037/0033-3204.45.1.28
21. Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63(7):757–66. DOI: 10.1001/archpsyc.63.7.757
22. Doering S, Hörz S, Rentrop M, Fischer-Kern M, Schuster P, Benecke C, et al. Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. Br J Psychiatry. 2010;196(5):389–95. DOI: 10.1192/bjp.bp.109.070177
23. Sachdeva S, Goldman G, Mustata G, Deranja E, Gregory RJ. Naturalistic outcomes of evidence-based therapies for borderline personality disorder at a university clinic a quasi-randomized trial. J Am Psychoanal Assoc. 2013;61(3):578–84. DOI: 10.1177/0003065113490637
24. McMain SF, Links PS, Gnam WH, Guimond T, Cardish RJ, Korman L et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. American Journal of Psychiatry. 2009.
25. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. American Journal of Psychiatry. 2009.
26. Jørgensen CR, Freund C, Bøye R, Jordet H, Andersen D, Kjølbye M. Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial. Acta Psychiatr Scand. 2013;127(4):305–17. DOI: 10.1111/j.1600-0447.2012.01923.x
27. Gabbard GO. Do all roads lead to Rome? New findings on borderline personality disorder. Am J Psychiatr. 2007;164(6):853–5. DOI: 10.1176/ajp.2007.164.6.853
28. Bateman AW, Krawitz R. Borderline personality disorder: an evidence-based guide for generalist mental health professionals. Oxford, United Kingdom: Oxford University Press; 2016.
29. Choi-Kain LW, Albert EB, Gunderson JG. Evidence-based treatments for borderline personality disorder: implementation, integration, and stepped care. Harvard Review of Psychiatry. 2016;24(5):342–56. DOI: 10.1097/HRP.0000000000000113
30. • Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A, Neacsiu AD, et al. Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA psychiatry. 2015;72(5):475–82. This is the first paper analyzing essential components of effective intensive treatment for BPD. DOI: 10.1001/jamapsychiatry.2014.3039
31. Farrell JM, Shaw IA, Webber MA. A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2009;40(2):317–28. DOI: 10.1016/j.jbtep.2009.01.002
32. Pennay A, Cameron J, Reichert T, Strickland H, Lee NK, Hall K, et al. A systematic review of interventions for co-occurring substance use disorder and borderline personality disorder. J Subst Abus Treat. 2011;41(4):363–73. DOI: 10.1016/j.jsat.2011.05.004
33. Kröger C, Schweiger U, Sipos V, Kliem S, Arnold R, Schunert T, et al. Dialectical behaviour therapy and an added cognitive behavioural treatment module for eating disorders in women with borderline personality disorder and anorexia nervosa or bulimia nervosa who failed to respond to previous treatments: an open trial with a 15-month follow-up. J Behav Ther Exp Psychiatry. 2010;41(4):381–8. DOI: 10.1016/j.jbtep.2010.04.001
34. Barnicot K, Priebe S. Post-traumatic stress disorder and the outcome of dialectical behaviour therapy for borderline personality disorder. Personal Ment Health. 2013;7(3):181–90. DOI: 10.1002/pmh.1227
35. Harned MS, Chapman AL, Dexter-Mazza ET, Murray A, Comtois KA, Linehan MM. Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by experts. J Consult Clin Psychol. 2008;76(6):1068–75. doi:10.1037/a0014044. DOI: 10.1037/a0014044
36. Harned MS, Korslund KE, Linehan MM. A pilot randomized controlled trial of Dialectical Behavior Therapy with and without the Dialectical Behavior Therapy Prolonged Exposure protocol for suicidal and self-injuring women with borderline personality disorder and PTSD. Behav Res Ther. 2014;55:7–17. DOI: 10.1016/j.brat.2014.01.008
37. Robinson P, Barrett B, Bateman A, Hakeem A, Hellier J, Lemonsky F, et al. Study protocol for a randomized controlled trial of mentalization based therapy against specialist supportive clinical management in patients with both eating disorders and symptoms of borderline personality disorder. BMC psychiatry. 2014;14(1):1. DOI: 10.1186/1471-244X-14-1
38. Lee NK, Cameron J, Jenner L. A systematic review of interventions for co-occurring substance use and borderline personality disorders. Drug and alcohol review. 2015;34(6):663–72. DOI: 10.1111/dar.12267
39. Linehan MM. Cognitive-behavioral treatment of borderline personality disorder: Guilford Press; 1993.
40. Linehan MM. Skills training manual for treating borderline personality disorder: Guilford Press; 1993.
41. Bateman A, Fonagy P. Mentalization-based treatment for borderline personality disorder: a practical guide. OUP Oxford; 2006.
42. Kernberg O. Borderline personality organization. J Am Psychoanal Assoc. 1967;15(3):641–85. DOI: 10.1177/000306516701500309
43. Gunderson JG, Lyons-Ruth K. BPD's interpersonal hypersensitivity phenotype: a gene-environment-developmental model. J Personal Disord. 2008;22(1):22. DOI: 10.1521/pedi.2008.22.1.22
44. McMain SF, Guimond T, Streiner DL, Cardish RJ, Links PS. Dialectical behavior therapy compared with general psychiatric management for borderline personality disorder: clinical outcomes and functioning over a 2-year follow-up. American Journal of Psychiatry. 2012.
45. Wnuk S, McMain S, Links PS, Habinski L, Murray J, Guimond T. Factors related to dropout from treatment in two outpatient treatments for borderline personality disorder. J Personal Disord. 2013;27(6):716. DOI: 10.1521/pedi_2013_27_106
46. Keuroghlian AS, Palmer BA, Choi-Kain LW, Borba CP, Links PS, Gunderson JG. The effect of attending good psychiatric management (GPM) workshops on attitudes toward patients with borderline personality disorder. J Personal Disord. 2015;1-10
47. Bateman A, Krawitz R. Borderline personality disorder: an evidence-based guide for generalist mental health professionals. Oxford: Oxford University Press; 2016.
48. Black DW, Simsek-Duran F, Blum N, McCormick B, Allen J. Do people with borderline personality disorder complicated by antisocial personality disorder benefit from the STEPPS treatment program? Personal Ment Health. 2016;10(3):205–15. doi:10.1002/pmh.1326. DOI: 10.1002/pmh.1326
49. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatr. 2004;161(11):2108–14. DOI: 10.1176/appi.ajp.161.11.2108
50. Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry. 1999;40(4):245–52. DOI: 10.1016/S0010-440X(99)90123-2
51. Gunderson JG, Stout RL, Shea MT, Grilo CM, Markowitz JC, Morey LC, et al. Interactions of borderline personality disorder and mood disorders over 10 years. J Clin Psychiatry. 2014;75(8):829–34. doi:10.4088/JCP.13m08972. DOI: 10.4088/JCP.13m08972
52. Bateman A, Fonagy P. Impact of clinical severity on outcomes of mentalisation-based treatment for borderline personality disorder. Br J Psychiatry. 2013;203(3):221–7. DOI: 10.1192/bjp.bp.112.121129
53. Boritz T, Barnhart R, McMain SF. The influence of posttraumatic stress disorder on treatment outcomes of patients with borderline personality disorder. J Personal Disord. 2016;30(3):395–407. DOI: 10.1521/pedi_2015_29_207
54. Linehan MM, Dimeff LA, Reynolds SK, Comtois KA, Welch SS, Heagerty P, et al. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend. 2002;67(1):13–26. DOI: 10.1016/S0376-8716(02)00011-X
55. Gregory RJ, Remen AL. A manual-based psychodynamic therapy for treatment-resistant borderline personality disorder. Psychotherapy: Theory, Research, Practice, Training. 2008;45(1):15. DOI: 10.1037/0033-3204.45.1.15
56. Telch CF, Agras WS, Linehan MM. Dialectical behavior therapy for binge eating disorder. J Consult Clin Psychol. 2001;69(6):1061. DOI: 10.1037/0022-006X.69.6.1061
57. Foa EB, Keane TM, Friedman MJ, Cohen JA. Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies. New York, NY: Guilford Press; 2009.
58. Zanarini MC, Frankenburg FR, Harned A, Fitzmaurice G. Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up. J Clin Psychopharmacol. 2015;35(1):63–7. DOI: 10.1097/JCP.0000000000000232
59. Zanarini MC, Frankenburg FR, Reich DB, Conkey LC, Fitzmaurice GM. Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study. Psychiatr Serv. 2014;66(1):15–20. DOI: 10.1176/appi.ps.201400055
60. Martinho Jr E, Fitzmaurice GM, Frankenburg FR, Zanarini MC. Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up. J Clin Psychopharmacol. 2014;34(4):499–503. DOI: 10.1097/JCP.0000000000000132
61. APA. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association: American Psychiatric Pub; 2001.
62. Kendall T, Burbeck R, Bateman A. Pharmacotherapy for borderline personality disorder: NICE guideline. Br J Psychiatry. 2010;196(2):158–9. DOI: 10.1192/bjp.196.2.158
63. National Institute for Clinical Excellence. Borderline personality disorder, treatment and management. The British Psychological society and the Royal College of Psychiatrists., London. 2009. https://www.nice.org.uk/guidance/cg78/chapter/1-Guidance. Accessed 09/02 2016.
64. Ingenhoven T, Lafay P, Rinne T, Passchier J, Duivenvoorden H. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. The Journal of clinical psychiatry. 2009;71(1):14–25. DOI: 10.4088/JCP.08r04526gre